Gastric dysplastic lesions in Helicobacter pylori-naïve stomach: Foveolar-type adenoma and intestinal-type dysplasia
- PMID: 38837872
- DOI: 10.1111/pin.13456
Gastric dysplastic lesions in Helicobacter pylori-naïve stomach: Foveolar-type adenoma and intestinal-type dysplasia
Abstract
Reports of Helicobacter pylori (Hp)-naïve gastric neoplasm (HpNGN) cases have been rapidly increasing due to the recent increase in the Hp-naïve population in Japan. Most HpNGNs exhibit the gastric immunophenotype and a low malignant potential regardless of histological type. Especially, foveolar-type gastric adenoma (FGA) and intestinal-type gastric dysplasia (IGD) rarely progress to invasive carcinoma. FGA is a foveolar epithelial neoplasm that occurs in the fundic gland (oxyntic gland) mucosa and is classified as the flat type or raspberry type (FGA-RA). The flat type is a large, whitish flatly elevated lesion while FGA-RA is a small reddish polyp. Genomically, the flat type is characterized by APC and KRAS gene mutations and FGA-RA by a common single nucleotide variant in the KLF4 gene. This KLF4 single-nucleotide variant reportedly induces gastric foveolar epithelial tumorigenesis and activates both cell proliferation and apoptosis, leading to its slow-growing nature. IGD consists of an intestinalized epithelial dysplasia that develops in the pyloric gland mucosa, characterized as a superficial depressed lesion surrounded by raised mucosa showing a gastritis-like appearance. Immunohistochemically, it exhibits an intestinal or gastrointestinal phenotype and, frequently, p53 overexpression. Thus, IGD shows unique characteristics in HpNGNs and a potential multistep tumorigenic process.
Keywords: Helicobacter pylori; KLF4; foveolar‐type gastric adenoma; gastric dysplasia; intestinal‐type gastric dysplasia.
© 2024 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.
References
REFERENCES
-
- Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, et al. AGA technical review on gastric intestinal metaplasia—natural history and clinical outcomes. Gastroenterology. 2020;158:705–731.e5.
-
- Yamada A, Kaise M, Inoshita N, Toba T, Nomura K, Kuribayashi Y, et al. Characterization of Helicobacter pylori‐naïve early gastric cancers. Digestion. 2018;98:127–134.
-
- Yamamoto Y, Fujisaki J, Omae M, Hirasawa T, Igarashi M. Helicobacter pylori‐negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551–561.
-
- Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34:609–619.
-
- Akazawa Y, Ueyama H, Hayashi T, Utsunomiya H, Uchida R, Abe D, et al. Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori‐uninfected patients: emphasis on differentiated gastric adenocarcinoma. J Gastroenterol. 2022;57:725–734.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous